Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Kaye

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Surgical Oncology|March 4, 2017
The role of adjuvant platinum-based chemotherapy in esophagogastric cancer patients who received neoadjuvant chemotherapy prior to definitive surgeryJohn H Saunders, Christopher R Bowman, Alex M Reece-Smith, et al.
Endoscopy|January 19, 2023
The effect of procedural time on dysplasia detection rate during endoscopic surveillance of Barrett's esophagusMathew Vithayathil, Ines Modolell, Jacobo Ortiz-Fernandez-Sordo, et al.
United European Gastroenterology Journal|October 29, 2025
Cancer Burden on Piecemeal Endoscopic Resection of Early Adenocarcinoma in Barrett's Oesophagus Correlates With the Risk of Neoplastic RecurrenceGrace J Hattersley, Andreas V Hadjinicolaou, Andrea Sorge, et al.
Hepatology (Baltimore, Md.)|August 30, 2012
Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver diseaseSudeep Tanwar, Paul M Trembling, Indra N Guha, et al.
Magma (New York, N.Y.)|December 20, 2022
Comparing magnetic resonance liver fat fraction measurements with histology in fibrosis: the difference between proton density fat fraction and tissue mass fat fractionStephen James Bawden, Caroline Hoad, Philip Kaye, et al.
Plos Pathogens|September 22, 2020
The glucosyltransferase activity of C. difficile Toxin B is required for disease pathogenesisTerry W Bilverstone, Megan Garland, Rory J Cave, et al.
NMR in Biomedicine|April 25, 2015
A study of T₁ relaxation time as a measure of liver fibrosis and the influence of confounding histological factorsCaroline L Hoad, Naaventhan Palaniyappan, Philip Kaye, et al.
Hepatology (Baltimore, Md.)|November 27, 2007
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markersIndra Neil Guha, Julie Parkes, Paul Roderick, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 20, 2022
Image-Enhanced Endoscopy and Molecular Biomarkers Vs Seattle Protocol to Diagnose Dysplasia in Barrett's EsophagusMathew Vithayathil, Ines Modolell, Jacobo Ortiz-Fernandez-Sordo, et al.
Scandinavian Journal of Gastroenterology|January 3, 2019
Narrow band imaging and serology in the assessment of premalignant gastric pathologyJonathan R White, Sarmed S Sami, Dona Reddiar, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Surgical Oncology|March 4, 2017
The role of adjuvant platinum-based chemotherapy in esophagogastric cancer patients who received neoadjuvant chemotherapy prior to definitive surgeryJohn H Saunders, Christopher R Bowman, Alex M Reece-Smith, et al.
Endoscopy|January 19, 2023
The effect of procedural time on dysplasia detection rate during endoscopic surveillance of Barrett's esophagusMathew Vithayathil, Ines Modolell, Jacobo Ortiz-Fernandez-Sordo, et al.
United European Gastroenterology Journal|October 29, 2025
Cancer Burden on Piecemeal Endoscopic Resection of Early Adenocarcinoma in Barrett's Oesophagus Correlates With the Risk of Neoplastic RecurrenceGrace J Hattersley, Andreas V Hadjinicolaou, Andrea Sorge, et al.
Hepatology (Baltimore, Md.)|August 30, 2012
Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver diseaseSudeep Tanwar, Paul M Trembling, Indra N Guha, et al.
Magma (New York, N.Y.)|December 20, 2022
Comparing magnetic resonance liver fat fraction measurements with histology in fibrosis: the difference between proton density fat fraction and tissue mass fat fractionStephen James Bawden, Caroline Hoad, Philip Kaye, et al.
Plos Pathogens|September 22, 2020
The glucosyltransferase activity of C. difficile Toxin B is required for disease pathogenesisTerry W Bilverstone, Megan Garland, Rory J Cave, et al.
NMR in Biomedicine|April 25, 2015
A study of T₁ relaxation time as a measure of liver fibrosis and the influence of confounding histological factorsCaroline L Hoad, Naaventhan Palaniyappan, Philip Kaye, et al.
Hepatology (Baltimore, Md.)|November 27, 2007
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markersIndra Neil Guha, Julie Parkes, Paul Roderick, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 20, 2022
Image-Enhanced Endoscopy and Molecular Biomarkers Vs Seattle Protocol to Diagnose Dysplasia in Barrett's EsophagusMathew Vithayathil, Ines Modolell, Jacobo Ortiz-Fernandez-Sordo, et al.
Scandinavian Journal of Gastroenterology|January 3, 2019
Narrow band imaging and serology in the assessment of premalignant gastric pathologyJonathan R White, Sarmed S Sami, Dona Reddiar, et al.
Pageof 5